Bloomberg News reports that Goldman Sachs and Bank of America will take home the lion’s share of that, with roles on both the $34.6bn purchase of Baker Hughes by Halliburton, and the $66bn acquisition of Allergan by Actavis.
Halliburton, the second-biggest oilfield services provider, agreed to buy No. 3 Baker Hughes, taking advantage of plunging crude prices to set up the biggest takeover of a U.S. energy company in three years. Actavis’s deal to acquire Allergan, meanwhile, will help the target rebuff a hostile approach from Valeant Pharmaceuticals International.
To access the complete Bloomberg News article hit the link below: